Fox-news/health/diabetes

• GLP-1 drugs may reach fewer than one in 10 people who need them, experts predict - The WHO issues its first official guidance on GLP-1 drugs for obesity treatment, as the disease affects over one billion people globally and is expected to double by 2030.